Search This Blog

Monday, December 29, 2025

Inovio stock tumbles after FDA questions accelerated approval path

 Inovio Pharmaceuticals Inc (NASDAQ:INO) stock plunged 21% Monday after the FDA raised concerns 

https://in.investing.com/news/stock-market-news/inovio-stock-tumbles-after-fda-questions-accelerated-approval-path-93CH-5167066

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)